Wasp Stings Treatment & Management

  • Author: Carl A Mealie, MD, FACEP, FAAEM; Chief Editor: Rick Kulkarni, MD   more...
 
Updated: Feb 4, 2011
 

Medical Care

Prehospital care and emergency department care

The "ABCs" of patient resuscitation and care take precedent. Airway patency and security is the prime concern, especially if there is any evidence of potential airway obstruction from angioedema manifested by stridor, hoarseness of voice, difficulty swallowing, or pooling of secretions. Breathing should be assessed for the rate, depth and adequacy of ventilation with pulse oximetry and auscultation of the chest to determine air movement, and the presence of wheezing from bronchial constriction and spasm. The patient's circulatory status should be evaluated for presence of distributive shock, assessing the blood pressure, nail bed capillary refill, and the patient's mental status.

Specific considerations

Local wound care

Apply ice to keep the area comfortably cool and to reduce swelling. Unlike honeybee stings, members of the wasp family (including hornets and yellow jackets) generally do not lose their stinging apparatus in the wound. Consider a secondary bacterial infection at the site in patients who present several days after the sting with fever or continued redness, warmth, swelling, and tenderness over the site or progression of the redness—red streaks that progress proximally.

Urticaria

Antihistamines remain the mainstay of therapy. H1 blockers such as oral diphenhydramine (Benadryl) or hydroxyzine (Atarax) have proven useful in reducing the severity of the itching and rash. Oral steroids (eg, prednisone, methylprednisolone [Medrol]) can be added to the regimen if needed, depending on the extent and severity of the patient's symptoms. Epinephrine, 0.3-0.5 mL subcutaneously in a 1:1000 solution, can also be used. Although it reverses the extent and itching of the urticaria, its benefit-to-risk ratio must be considered. The alpha effect of epinephrine increases the systemic vascular resistance, while its beta effect has a positive inotropic and chronotropic effect on the heart. This produces an increase in the heart's work and increases the myocardial oxygen demand. This may have a deleterious effect in patients with preexisting heart disease or coronary artery disease.

Anaphylaxis

The patient may present with airway obstruction due to angioedema, respiratory compromise due to bronchospasm, or circulatory collapse or with a combination of these 3 conditions. Follow the ABCs of emergency medicine as expediently as possible. The airway must be secured. Intubate the patient with rapid sequence technique upon evidence of impending airway obstruction due to swelling or evidence of respiratory failure due to bronchospasm. Establish 2 large-bore intravenous lines to provide a route for medication administration and for fluid bolus in the event of circulatory collapse. Place the patient on both pulse oximetry and a cardiac monitor.

Angioedema

If intubation is impossible because of the degree of swelling, obtain a surgical airway through cricothyrotomy. Surgical cricothyrotomy is contraindicated in patients younger than 8 years. In these cases, perform needle cricothyrotomy using the largest-bore needle practical as a temporizing measure. Obtain an emergency consultation with an anesthesiologist and an otorhinolaryngologist (ENT) to prepare the child for the operating room for definitive angioedema/airway management if parenteral beta agonists, histamine 1 (H1) blockers, and glucocorticoids do not relieve the obstruction.

Bronchospasm

Treatment of bronchospasm without obstruction depends on the acuity of the patient's presentation. Treat mild-to-moderate distress with a combination of nebulized beta agonist (eg, albuterol 0.5 mL of 0.5% solution in 2.5 mL of normal saline nebulized q15min) and parenteral glucocorticoids (eg, methylprednisolone 125 mg IV). As the severity of the respiratory distress increases, weigh the benefit-to-risk ratio of using a parenteral beta agonist (eg, epinephrine). As bronchospasm worsens, a point of peaked expiratory flow and forced expiratory volume decrease occurs and the only area being ventilated with the nebulized beta agonist is the appropriately named dead space.

Epinephrine, 0.3-0.5 mL of a 1:1000 solution, may be administered intramuscularly. Its onset of action should be 3-5 minutes; however, impending circulatory collapse with peripheral vasoconstriction due to anaphylaxis may make this route ineffective. Intravenous epinephrine using 3-5 mL (0.3-0.5 mg) of the 1:10,000 solution (0.1 mg/mL) diluted in 10 mL of normal saline or distilled water should be administered slowly over a 1- to 2-minute period, depending on the patient's condition.[3]

As an alternative, 3-5 mL of 1:10,000 solution can also be administered via the endotracheal tube. Administer this solution via a catheter with the tip placed below the end of the endotracheal tube and then flushed through with several milliliters of saline or distilled water. Several positive ventilations follow to force the epinephrine into the terminal bronchioles and alveoli.

Vasopressin 40 IU has also been used for refractory hypotension.

Hypotension

The cause of hypotension is multifactorial. Histamine, prostaglandin, and leukotriene can reduce the systemic vascular resistance by vasodilating the peripheral vessels and increase the capillary endothelial permeability, allowing extravasation of fluid into the third space. The net effect of both of these processes increases the vascular bed and decreases the amount of fluid in the vascular compartment. Begin treatment with the establishment of 2 large-bore intravenous lines and crystalloid fluid boluses. Vasopressors then can be added, depending on the patient's clinical appearance. Epinephrine can be administered via continuous infusion by mixing 1 mg in 250 mL of normal saline and infusing at a rate of 0.5-1 mL/min. Norepinephrine (Levophed) can also be used. It has the advantage of having more of an alpha effect and less of a beta effect than epinephrine.

Next

Surgical Care

Consider a surgical airway in any patient with evidence of upper airway edema or laryngeal spasm who is experiencing respiratory deterioration. The equipment and expertise to perform a cricothyrotomy should be readily available if orotracheal or nasotracheal intubation cannot be achieved.

Previous
Next

Consultations

A consultation with an otorhinolaryngologist may be necessary to visualize the epiglottic and supraglottic regions with a flexible fiberoptic laryngoscope in patients who experience throat tightness or throat closing and who present with little or no objective signs of airway compromise.

In patients with symptoms of throat tightness or throat closing with mild-to-moderate signs of airway compromise or patients who have evidence of early airway obstruction on flexible fiberoptic laryngoscopy, consultation with an anesthesiologist may be necessary to assist in securing the airway.

Patients who have moderate-to-severe signs and symptoms of airway compromise, such as increasing dyspnea, hoarseness, dysphagia, inability to clear secretions, use of accessory muscles, or decreasing oxygen saturation on pulse oximetry, require emergent consultation with both an anesthesiologist and an otorhinolaryngologist to place a surgical airway if intubation is unsuccessful. Rapid sequence intubation in these patients should be used with caution. The airway may be maintained open only by the patient's laryngeal muscles. The use of paralytics may allow the airway to be completely occluded.

Previous
Next

Activity

Advise patients who have experienced an allergic reaction to prior wasp stings or to any Hymenoptera stings to exercise caution while outdoors during mild-to-warm weather. Advise these patients to avoid wearing any scented material (eg, perfume, hairspray, soaps, deodorants, sunscreen). Brightly colored clothing, especially floral designs, should be avoided. Tell patients who have experienced a severe reaction to a wasp sting to curtail solitary outdoor activities. Advise that the patient should be accompanied when outdoors and away from populated areas (eg, hiking, fishing) in case help is needed.

Because odors tend to attract wasps, tell patients and their families to examine the home environment to decrease risks of attracting insects. Cover garbage pails. Remove rotting fruit on the vine or tree or after having fallen to the ground.

Encourage patients to carry EpiPen auto-injectors when outdoors and to have one device in the home. Advise the patient that auto-injectors left in the car for prolonged periods during hot days may not be effective. They should periodically review the expiration date of the auto-injectors.

Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Carl A Mealie, MD, FACEP, FAAEM  Assistant Professor, Department of Emergency Medicine, Albert Einstein College of Medicine; Chief of Operations, Department of Emergency Medicine, Long Island Jewish Medical Center

Carl A Mealie, MD, FACEP, FAAEM is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Physicians, American Medical Association, New York Academy of Medicine, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

Alan S Multz, MD  Associate Professor of Clinical Medicine, Albert Einstein College of Medicine; Program Director, Internal Medicine Residency, Associate Chairman, Department of Medicine, Long Island Jewish Medical Center

Alan S Multz, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Chest Physicians, American College of Physicians, American Thoracic Society, and Society of Critical Care Medicine

Disclosure: Astellas Pharmaceutical Honoraria Consulting; Merck Pharmaceutical Honoraria Speaking and teaching; The Medicines Company Honoraria Consulting; Schering Plough Honoraria Speaking and teaching; Wyeth Pharmaceuticals Honoraria Speaking and teaching; Pfizer Honoraria Speaking and teaching

Max Vernon Wisgerhof II, MD  Fellowship Program Director, Department of Endocrinology and Metabolism, Henry Ford Hospital

Max Vernon Wisgerhof II, MD is a member of the following medical societies: American Thyroid Association and Endocrine Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Lisa Kirkland, MD, FACP, CNSP, MSHA  Assistant Professor, Department of Internal Medicine, Division of Hospital Medicine, Mayo Clinic; ANW Intensivists, Abbott Northwestern Hospital

Lisa Kirkland, MD, FACP, CNSP, MSHA is a member of the following medical societies: American College of Physicians, Society of Critical Care Medicine, and Society of Hospital Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Timothy D Rice, MD  Associate Professor, Departments of Internal Medicine and Pediatrics and Adolescent Medicine, St Louis University School of Medicine

Timothy D Rice, MD is a member of the following medical societies: American Academy of Pediatrics and American College of Physicians

Disclosure: Nothing to disclose.

Chief Editor

Rick Kulkarni, MD  Attending Physician, Department of Emergency Medicine, Cambridge Health Alliance, Division of Emergency Medicine, Harvard Medical School

Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: WebMD Salary Employment

References
  1. Pumphrey RS, Roberts IS. Postmortem findings after fatal anaphylactic reactions. J Clin Pathol. Apr 2000;53(4):273-6. [Medline].

  2. Diaz JH. The impact of hurricanes and flooding disasters on hymenopterid-inflicted injuries. Am J Disaster Med. Sep-Oct 2007;2(5):257-69. [Medline].

  3. Barach EM, Nowak RM, Lee TG, et al. Epinephrine for treatment of anaphylactic shock. JAMA. Apr 27 1984;251(16):2118-22. [Medline].

  4. EpiPen EpiPen JR [package insert]. NAPA California: Dey; 2009.

  5. Ruëff F, Przybilla B. Venom immunotherapy. Side effects and efficacy of treatment. Hautarzt. Mar 2008;59(3):200-5. [Medline].

  6. Vachvanichsanong P, Dissaneewate P. Acute renal failure following wasp sting in children. Eur J Pediatr. Aug 2009;168(8):991-4. [Medline].

  7. Rekik S, Andrieu S, Aboukhoudir F, Barnay P, Quaino G, Pansieri M, et al. ST Elevation Myocardial Infarction with No Structural Lesions after a Wasp Sting. J Emerg Med. Mar 26 2009;[Medline].

  8. Jairam A, Kumar RS, Ghosh AK, Hasija PK, Singh JI, Mahapatra D, et al. Delayed Kounis syndrome and acute renal failure after wasp sting. Int J Cardiol. Aug 13 2008;[Medline].

  9. Andrewes CH. The lives of Wasps and Bees. New York, NY: American Elsevier Publishing Co; 1969.

  10. Austen KF. Diseases of immediate sensitivity. In: Fauci AS, ed. Harrison's Principles of Internal Medicine. New York, NY: McGraw Hill; 1998:1860-1869.

  11. Bohlke K, Davis RL, DeStefano F, Marcy SM, Braun MM, Thompson RS. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol. Mar 2004;113(3):536-42. [Medline].

  12. Boxer MB, Greenberger PA, Patterson R. The impact of prednisone in life-threatening idiopathic anaphylaxis: reduction in acute episodes and medical costs. Ann Allergy. Mar 1989;62(3):201-4. [Medline].

  13. Fadal RG. IgE-mediated hypersensitivity reactions. Otolaryngol Head Neck Surg. Sep 1993;109(3 Pt 2):565-78. [Medline].

  14. Golden DK. Immunology Allergy Clinics of North America. 2000;20(3):553-570. [Full Text].

  15. Hauk P, Friedl K, Kaufmehl K, et al. Subsequent insect stings in children with hypersensitivity to Hymenoptera. J Pediatr. Feb 1995;126(2):185-90. [Medline].

  16. Li JT, Yunginger JW. Management of insect sting hypersensitivity. Mayo Clin Proc. Feb 1992;67(2):188-94. [Medline].

  17. Muellman RL, Lindzon RD, Silvers NS. Allergy, hypersensitivity and anaphylaxis. In: Rosen P, ed. Emergency Medicine, Concepts and Clinical Practice. 4th ed. St. Louis, Mo: Mosby Year Book; 1998:2759-2776.

  18. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report--second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med. Apr 2006;47(4):373-80. [Medline].

  19. Settipane GA, Boyd GK. Anaphylaxis from insect stings. Myths, controversy, and reality. Postgrad Med. Aug 1989;86(2):273-6, 278, 280-1. [Medline].

  20. Thomas M, Crawford I. Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emerg Med J. Apr 2005;22(4):272-3. [Medline].

Previous
Next
 
A paper wasp (Randy Park, MD)
A paper wasp (Randy Park, MD)
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.